Updated August 2026. The UAE pharmaceutical sector is one of the most tightly regulated commercial activities in the country, governed by a multi-layered framework of federal and emirate-level approvals. This guide explains the complete process for obtaining pharmaceutical import permits, drug registration, GDP-certified warehousing, controlled substance licensing, and national distributor arrangements for the UAE market in 2026.
- All pharmaceutical products must be registered with MoHAP (Ministry of Health and Prevention) before they can be marketed or distributed in the UAE.
- Drug import permits are required for each consignment and cost approximately AED 200–500 per permit via the MoHAP MOHAP Connect portal.
- A licensed national distributor (sole agent) arrangement is required for foreign pharmaceutical manufacturers entering the UAE market.
- Pharmaceutical warehouses must be GDP (Good Distribution Practice) certified and comply with UAE temperature-controlled storage standards.
- Total setup costs for a pharmaceutical import and distribution business in UAE range from AED 50,000 to AED 100,000 in first-year licensing and regulatory fees.
UAE Pharmaceutical Regulatory Framework
The UAE pharmaceutical sector operates under a dual regulatory structure. At the federal level, the Ministry of Health and Prevention (MoHAP) is the primary authority for drug registration, import licensing, and pharmaceutical company regulation nationwide. At the emirate level, Dubai Health Authority (DHA) and Department of Health Abu Dhabi (DoH) exercise concurrent jurisdiction in their respective emirates, particularly for healthcare facilities, retail pharmacy licensing, and local pharmaceutical sales approvals.
Federal Law No. 4 of 1983 on Pharmaceutical Practice, as amended, forms the backbone of UAE pharmaceutical law. This law and its implementing regulations cover drug registration, import and export of medicines, manufacturing standards, controlled substances, advertising of pharmaceuticals, and pharmacist licensing. The UAE also adopts guidelines from the International Council for Harmonisation (ICH) and World Health Organization (WHO) as reference standards for drug quality, safety, and efficacy assessment.
Pharmaceutical companies operating in the UAE must employ a licensed pharmacist as a Responsible Person (RP) or Technical Manager. The RP is personally accountable to MoHAP for the company pharmaceutical activities and must hold a valid UAE pharmacist license issued by the Health Authority. Pharmacist license renewal is due annually and requires evidence of continuing professional development (CPD) activities.
MoHAP Drug Registration: The Product Dossier
No pharmaceutical product can be marketed or distributed in the UAE without prior registration by MoHAP. Drug registration is a comprehensive technical assessment process covering the product quality, safety, and clinical efficacy data. Applications are submitted through the MoHAP Connect portal (mohapconnect.gov.ae) and require the submission of a full Common Technical Document (CTD) dossier in modules conforming to ICH M4 guidelines.
The key components of a UAE drug registration dossier include: Module 1 (administrative information including the product summary, labelling, and packaging artwork for UAE market); Module 2 (quality, non-clinical, and clinical summaries and overviews); Module 3 (pharmaceutical quality data including manufacturing process, analytical testing, and stability data); Module 4 (non-clinical study reports); and Module 5 (clinical study reports and post-marketing safety data).
Registration fees payable to MoHAP vary by product category: new molecular entities (AED 15,000–25,000), generic medicines (AED 5,000–10,000), biological and biosimilar products (AED 25,000–50,000), and dietary supplements or medical devices (AED 3,000–8,000). The review timeline for standard applications is approximately 12–18 months. Expedited review is available for products with WHO prequalification or EMA/FDA marketing authorisation, reducing the timeline to approximately 6–9 months. Annual registration renewal fees are approximately 50% of the initial registration fee.
MoHAP Drug Import Permit
Even for registered pharmaceutical products, each individual shipment into the UAE requires a separate Drug Import Permit (DIP) from MoHAP. This permit is applied for through MoHAP Connect by the licensed national distributor or the pharmaceutical company branch registered in the UAE. The application includes the product registration certificate number, the quantity and batch details of the shipment, the manufacturing site details, and the supplier and shipper information.
Drug Import Permit fees are approximately AED 200–500 per permit, depending on the number of product lines in the shipment. The permit is typically issued within 3–7 working days for routine shipments of registered products. Upon arrival in the UAE, the shipment is subject to documentary verification and may be subject to physical sample testing by MoHAP or the Drug Control Department laboratory before customs releases the goods from the port.
Pharmaceutical products that arrive without a valid Drug Import Permit are detained by customs authorities and the national distributor is notified to obtain the permit or arrange re-export. Repeat violations of the import permit requirement can result in suspension of the company pharmaceutical trading license. Emergency drug import permits for critical medicines not yet registered in the UAE can be issued on a compassionate use basis, subject to MoHAP approval and a special application process.
Controlled Substance License
Pharmaceutical products classified as controlled substances under UAE Federal Decree-Law No. 30 of 2021 on Combating Narcotic Drugs and Psychotropic Substances require an additional Controlled Substance License from MoHAP before they can be imported, stored, or distributed. Controlled substances include narcotics (morphine, fentanyl, oxycodone), psychotropic substances (diazepam, zolpidem, methylphenidate), and precursor chemicals used in drug manufacturing.
The Controlled Substance License is separate from and in addition to the standard pharmaceutical trading license. Application involves: submission of detailed floor plans showing secure storage facilities; installation of a controlled access vault or safe room meeting MoHAP specifications; appointment of a licensed pharmacist specifically responsible for controlled substances; and a formal audit by MoHAP inspectors before the license is granted. Annual license fees for controlled substance import and distribution are AED 10,000–20,000 depending on the category of controlled substances handled.
Companies holding a Controlled Substance License must maintain detailed stock control records (controlled substance register) with batch-level traceability, submit monthly reports to MoHAP detailing receipts, issues, and closing stock, and undergo regular announced and unannounced MoHAP inspections. Any discrepancies in controlled substance stock are treated as a serious regulatory matter and may result in license suspension and criminal investigation.
GDP-Certified Warehouse Requirements
All pharmaceutical storage and distribution facilities in the UAE must comply with Good Distribution Practice (GDP) guidelines based on the WHO Technical Report Series No. 957 (WHO Expert Committee on Specifications for Pharmaceutical Preparations, Annex 5, 2010) and the UAE Cabinet Decision No. 7 of 2018 on GDP guidelines. GDP certification is granted by MoHAP following a formal inspection of the pharmaceutical warehouse.
Key GDP requirements for UAE pharmaceutical warehouses include: temperature-controlled storage areas compliant with WHO storage condition zones (Zone IVb: 30°C / 65% relative humidity for general medicines; 2–8°C cold chain for refrigerated products; -20°C for frozen biologics); continuous temperature and humidity monitoring with calibrated data loggers and alarm systems; validated cold room or refrigerator equipment with backup power supply; segregated storage areas for quarantine, released, rejected, and recalled stock; and a trained GDP-compliant staff with documented training records.
Warehouse lease in a UAE logistics park meeting GDP standards (Technopark, Dubai Industrial City, JAFZA logistics zone) typically costs AED 40–80 per square metre per year for a temperature-controlled facility. A minimum 500 m2 facility with full GDP fit-out — including cold rooms, monitoring systems, and IT infrastructure for warehouse management — can cost AED 300,000–600,000 in capital expenditure, in addition to ongoing lease costs.
Cold Chain Logistics for Pharmaceuticals
A significant and growing category of pharmaceutical imports into the UAE requires cold chain logistics: vaccines, insulin and other biologics, monoclonal antibodies, some diagnostic reagents, and certain speciality medicines must be maintained within a continuous temperature-controlled supply chain from the manufacturer to the patient. The UAE pharmaceutical cold chain market has grown significantly with the expansion of the biologics and specialty pharma segment and the experience gained during COVID-19 vaccine logistics.
UAE pharmaceutical cold chain service providers include DHL Supply Chain UAE, Agility UAE, GAC Logistics, Fiege Pharma UAE, and specialised local operators. These providers offer GDP-compliant cold room storage, refrigerated vehicles with temperature data loggers, export packaging validation, and 24/7 monitoring for high-value cold-chain products. Cold chain storage costs in the UAE range from AED 8–15 per pallet per day for 2–8°C products and AED 20–40 per pallet per day for ultra-low temperature (-70°C) storage.
National Distributor (Sole Agent) Arrangement
Foreign pharmaceutical manufacturers wishing to market their products in the UAE must appoint a UAE-registered pharmaceutical company as their national distributor (also known as a sole agent or marketing authorisation holder). The national distributor holds the product registration in their name in the UAE, acts as the point of contact for MoHAP, and is responsible for all regulatory submissions, pharmacovigilance reporting, and product recall activities in the UAE market.
National distributor agreements are typically exclusive arrangements covering the entire UAE market (seven emirates). The distributor receives a margin of 15–35% depending on the product category and market size. Leading national distributors in the UAE pharmaceutical sector include Julphar (Gulf Pharmaceutical Industries), Rafed (National Health Insurance Company subsidiary), Galenica, Al Zahrawi Medical Supplies, and Pharmatrade.
When entering or terminating a national distributor relationship, pharmaceutical manufacturers must be aware of UAE Commercial Agency Law (Federal Law No. 18 of 1981, as amended by Federal Law No. 11 of 1992). Registered commercial agents in the UAE have strong legal protections, and terminating an exclusive distribution agreement without the agent consent can result in significant compensation claims. Companies should seek UAE legal advice before entering national distributor agreements.
Pharmacist Manager Requirement for Pharmaceutical Companies
Any UAE entity involved in the import, distribution, storage, or retail sale of pharmaceutical products must appoint a licensed pharmacist as the Responsible Person or Technical Manager. This individual must hold a valid UAE pharmacist license, which requires: a recognised pharmacy degree (B.Pharm, M.Pharm, or Pharm.D) from a university accredited by the UAE Ministry of Education; licensing examination with the relevant Health Authority (DHA, DoH, or MoH); UAE residency and work permit; and annual CPD of at least 30 credit hours.
The pharmacist manager is personally responsible to MoHAP for the pharmaceutical activities of the company. This includes authorising drug import permits, signing GDP compliance declarations, maintaining the controlled substances register, and ensuring pharmacovigilance reporting obligations are met. A single pharmacist cannot simultaneously serve as the responsible person for more than one pharmaceutical company, ensuring adequate oversight of each licensed entity.
| Regulatory Step | Authority | Cost (AED) | Timeline |
|---|---|---|---|
| Pharmaceutical trading license | DET / MoHAP | 20,000–35,000 | 4–8 weeks |
| Drug registration (generic) | MoHAP | 5,000–10,000 per product | 12–18 months |
| Drug Import Permit (per shipment) | MoHAP | 200–500 per permit | 3–7 working days |
| Controlled substance license | MoHAP | 10,000–20,000/year | 8–12 weeks |
| GDP warehouse certification | MoHAP | 5,000–15,000 | 6–10 weeks |
| Pharmacist manager license | DHA / DoH / MoH | 3,000–6,000/year | 4–8 weeks |
How do I register a pharmaceutical product in the UAE?
Pharmaceutical products are registered with MoHAP through the MoHAP Connect portal. You must submit a full CTD dossier (Modules 1-5) with quality, safety, and efficacy data. Registration fees are AED 5,000-10,000 for generics and AED 15,000-25,000 for new molecular entities. Review takes 12-18 months; expedited review (6-9 months) is available for WHO-prequalified or EMA/FDA-approved products.
Do I need a drug import permit for every pharmaceutical shipment to UAE?
Yes. Every pharmaceutical shipment into the UAE requires a separate Drug Import Permit (DIP) from MoHAP, even for registered products. Permits cost AED 200-500 and are issued within 3-7 working days via MoHAP Connect. Shipments arriving without a valid permit are detained by customs and may face re-export obligations.
What are the GDP warehouse requirements for pharmaceuticals in UAE?
UAE pharmaceutical warehouses must comply with WHO GDP guidelines: continuous temperature monitoring, temperature-controlled storage zones (Zone IVb: 30C/65% RH for general products; 2-8C for cold chain), validated equipment with backup power, segregated quarantine and release areas, and trained staff with documented records. MoHAP GDP certification is mandatory before a pharmaceutical distribution license is issued.
Is a pharmacist required to run a UAE pharmaceutical distribution company?
Yes. UAE law requires any pharmaceutical trading, distribution, or storage company to appoint a licensed pharmacist as the Responsible Person or Technical Manager. The pharmacist must hold a valid UAE health authority license, cannot simultaneously serve as RP for more than one company, and is personally accountable to MoHAP for the company regulatory compliance.
What is a sole agent arrangement for pharmaceuticals in UAE?
A sole agent (national distributor) is a UAE-registered pharmaceutical company appointed exclusively by a foreign manufacturer to market and distribute their products in the UAE. The agent holds the product registration, submits import permits, and handles pharmacovigilance. UAE Commercial Agency Law provides strong legal protections for registered agents, so manufacturers should seek legal advice before signing or terminating exclusive distribution agreements.